2022 annual financial data
Vistagen Therapeutics 2022 Net income growth
Direct answer
Net income growth was -166.32%.
Operating income was -47,778,900 USD and net income was -47,762,400 USD.
Operating cash flow was -45,256,500 USD.
Get free Vistagen Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,108,900 USD
- Operating income
- -47,778,900 USD
- Net income
- -47,762,400 USD
- Operating cash flow
- -45,256,500 USD